Anlon Healthcare Ltd vs Citichem India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 114.45 as of 23 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Citichem India Ltd changed from 14 on March 2025 to 14 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Citichem India Ltd changed from ₹ 17.25 crore on March 2025 to ₹ 17.25 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Citichem India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Citichem India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Citichem India Ltd changed from ₹ 0.2 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Citichem India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Citichem India Ltd

Citichem India Limited was incorporated as Citichem Alkalies (Bombay) Private Limited' dated March 18, 1992 at Maharashtra.
Further, Company was converted into public limited company and consequently name of Company was changed to Citichem Alkalies (Bombay) Limited' dated March 23, 1999.
Thereafter, the Company was further changed from Citichem Alkalies (Bombay) Limited' to Citichem India Ltd' pursuant to fresh certificate of incorporation dated April 17, 1999, issued by Registrar of Companies, Maharashtra.
Company made a fresh issue of 18,00,000 Equity Shares of Rs 10/- by raising funds through IPO aggregating up to Rs. 12.6 Cr in December, 2024. Citichem India Limited is one of the largest distributor of Industrial Chemicals.
The Company has wide applications in Textile & Garments, Pharmaceuticals, Finished Formulations, Key Starting Materials for API, Bulk Drugs and Intermediates, Paints, Coatings, Food, Fragrance & Perfumes, Pesticides and Agro Chemicals.

FAQs for the comparison of Anlon Healthcare Ltd and Citichem India Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Citichem India Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of Citichem India Ltd is 9 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Citichem India Ltd?

The stock performance of Anlon Healthcare Ltd and Citichem India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Citichem India Ltd?

As of March 23, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, Citichem India Ltd stock price is INR ₹14.1.

How do dividend payouts of Anlon Healthcare Ltd and Citichem India Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Citichem India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.